Skip to main content
. 2020 Aug 15;12(8):808–832. doi: 10.4251/wjgo.v12.i8.808

Figure 1.

Figure 1

5-year disease free survival rate in stage III colon cancer patients treated with standard adjuvant chemotherapy regimens. 1X-ACT trial[92]; 2NSABP-C07[17,90]; 3MOSAIC trial[53,76]; 4NO16968/XELOXA[16].